TY - JOUR
T1 - Stroke Warning Information and Faster Treatment (SWIFT)
T2 - Cost-Effectiveness of a Stroke Preparedness Intervention
AU - Stevens, Elizabeth R.
AU - Roberts, Eric
AU - Kuczynski, Heather Carman
AU - Boden-Albala, Bernadette
N1 - Publisher Copyright:
© 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research
PY - 2019/11
Y1 - 2019/11
N2 - Background: Less than 25% of stroke patients arrive to an emergency department within the 3-hour treatment window. Objective: We evaluated the cost-effectiveness of a stroke preparedness behavioral intervention study (Stroke Warning Information and Faster Treatment [SWIFT]), a stroke intervention demonstrating capacity to decrease race-ethnic disparities in ED arrival times. Methods: Using the literature and SWIFT outcomes for 2 interventions, enhanced educational (EE) materials, and interactive intervention (II), we assess the cost-effectiveness of SWIFT in 2 ways: (1) Markov model, and (2) cost-to-outcome ratio. The Markov model primary outcome was the cost per quality-adjusted life-year (QALY) gained using the cost-effectiveness threshold of $100 000/QALY. The primary cost-to-outcome endpoint was cost per additional patient with ED arrival <3 hours, stroke knowledge, and preparedness capacity. We assessed the ICER of II and EE versus standard care (SC) from a health sector and societal perspective using 2015 USD, a time horizon of 5 years, and a discount rate of 3%. Results: The cost-effectiveness of the II and EE programs was, respectively, $227.35 and $74.63 per additional arrival <3 hours, $440.72 and $334.09 per additional person with stroke knowledge proficiency, and $655.70 and $811.77 per additional person with preparedness capacity. Using a societal perspective, the ICER for EE versus SC was $84 643 per QALY gained and the ICER for II versus EE was $59 058 per QALY gained. Incorporating fixed costs, EE and II would need to administered to 507 and 1693 or more patients, respectively, to achieve an ICER of $100 000/QALY. Conclusion: II was a cost-effective strategy compared with both EE and SC. Nevertheless, high initial fixed costs associated with II may limit its cost-effectiveness in settings with smaller patient populations.
AB - Background: Less than 25% of stroke patients arrive to an emergency department within the 3-hour treatment window. Objective: We evaluated the cost-effectiveness of a stroke preparedness behavioral intervention study (Stroke Warning Information and Faster Treatment [SWIFT]), a stroke intervention demonstrating capacity to decrease race-ethnic disparities in ED arrival times. Methods: Using the literature and SWIFT outcomes for 2 interventions, enhanced educational (EE) materials, and interactive intervention (II), we assess the cost-effectiveness of SWIFT in 2 ways: (1) Markov model, and (2) cost-to-outcome ratio. The Markov model primary outcome was the cost per quality-adjusted life-year (QALY) gained using the cost-effectiveness threshold of $100 000/QALY. The primary cost-to-outcome endpoint was cost per additional patient with ED arrival <3 hours, stroke knowledge, and preparedness capacity. We assessed the ICER of II and EE versus standard care (SC) from a health sector and societal perspective using 2015 USD, a time horizon of 5 years, and a discount rate of 3%. Results: The cost-effectiveness of the II and EE programs was, respectively, $227.35 and $74.63 per additional arrival <3 hours, $440.72 and $334.09 per additional person with stroke knowledge proficiency, and $655.70 and $811.77 per additional person with preparedness capacity. Using a societal perspective, the ICER for EE versus SC was $84 643 per QALY gained and the ICER for II versus EE was $59 058 per QALY gained. Incorporating fixed costs, EE and II would need to administered to 507 and 1693 or more patients, respectively, to achieve an ICER of $100 000/QALY. Conclusion: II was a cost-effective strategy compared with both EE and SC. Nevertheless, high initial fixed costs associated with II may limit its cost-effectiveness in settings with smaller patient populations.
KW - acute stroke
KW - cost-effectiveness
KW - health literacy
KW - patient education
KW - patient-centered outcomes research
KW - preparedness
UR - http://www.scopus.com/inward/record.url?scp=85069663531&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069663531&partnerID=8YFLogxK
U2 - 10.1016/j.jval.2019.06.003
DO - 10.1016/j.jval.2019.06.003
M3 - Article
AN - SCOPUS:85069663531
SN - 1098-3015
VL - 22
SP - 1240
EP - 1247
JO - Value in Health
JF - Value in Health
IS - 11
ER -